Evidence map›Paper›PMID 23033477›Full record

ArticleMolecular & cellular proteomics : MCP2013

High resolution quantitative proteomics of HeLa cells protein species using stable isotope labeling with amino acids in cell culture(SILAC), two-dimensional gel electrophoresis(2DE) and nano-liquid chromatograpohy coupled to an LTQ-OrbitrapMass spectrometer.

Bernd Thiede, Christian J Koehler, Margarita Strozynski, Achim Treumann, Robert Stein, Ursula Zimny-Arndt, Monika Schmid, Peter R Jungblut

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Quantitative Aspects of the Human Cell Proteome.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Proteomics in Multiple Sclerosis: The Perspective of the Clinician.International journal of molecular sciences · 2022
    Review
  9. Plants (Basel, Switzerland) · 2021
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Proteomic Profiling ofMolecules (Basel, Switzerland) · 2020
    Article
  16. Empowering Shotgun Mass Spectrometry with 2DE: A HepG2 Study.International journal of molecular sciences · 2020
    Article
  17. Predominant cleavage of proteins N-terminal to serines and threonines using scandium(III) triflate.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Bernd ThiedeThe Biotechnology Centre of Oslo, University of Oslo, Gaustadalleen 21, 0349 Oslo, Norway. bernd.thiede@biotek.uio.no
Christian J Koehler
Margarita Strozynski
Achim Treumann
Robert Stein
Ursula Zimny-Arndt
Monika Schmid
Peter R Jungblut
University of Oslo · NOMax Planck Institute for Infection Biology · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteomics field has shifted over recent years from two-dimensional gel electrophoresis (2-DE)-based approaches to SDS-PAGE or gel-free workflows because of the tremendous developments in isotopic labeling techniques, nano-liquid chromatography, and high-resolution mass spectrometry. However, 2-DE still offers the highest resolution in protein separation. Therefore, we combined stable isotope labeling with amino acids in cell culture of controls and apoptotic HeLa cells with 2-DE and the subsequent analysis of tryptic peptides via nano-liquid chromatography coupled to an LTQ-Orbitrap mass spectrometer to obtain quantitative data using the methods with the highest resolving power on all levels of the proteomics workflow. More than 1,200 proteins with more than 2,700 protein species were identified and quantified from 816 Coomassie Brilliant Blue G-250 stained 2-DE spots. About half of the proteins were identified and quantified only in single 2-DE spots. The majority of spots revealed one to five proteins; however, in one 2-DE spot, up to 23 proteins were identified. Only half of the 2-DE spots represented a dominant protein with more than 90% of the whole protein amount. Consequently, quantification based on staining intensities in 2-DE gels would in approximately half of the spots be imprecise, and minor components could not be quantified. These problems are circumvented by quantification using stable isotope labeling with amino acids in cell culture. Despite challenges, as shown in detail for lamin A/C and vimentin, the quantitative changes of protein species can be detected. The combination of 2-DE with high-resolution nano-liquid chromatography-mass spectrometry allowed us to identify proteomic changes in apoptotic cells that would be unobservable using any of the other previously employed proteomic workflows.

Indexed as

ArtifactsApoptosisChromatography, LiquidCysteineElectrophoresis, Gel, Two-DimensionalHeLa CellsHumansIsotope LabelingMass SpectrometryPeptidesProteomeProteomicsRosaniline Dyes3-tritylthio-L-alaninecoomassie Brilliant BlueCysteinePeptidesProteomeRosaniline Dyes

Identifiers

PMID23033477
PMCPMC3567871
OpenAlexW2157304217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.